179 related articles for article (PubMed ID: 31545001)
1. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
[TBL] [Abstract][Full Text] [Related]
2. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.
Kind S; Kluth M; Hube-Magg C; Möller K; Makrypidi-Fraune G; Lutz F; Lennartz M; Rico SD; Schlomm T; Heinzer H; Höflmayer D; Weidemann S; Uhlig R; Huland H; Graefen M; Bernreuther C; Tsourlakis MC; Minner S; Dum D; Hinsch A; Lübke AM; Simon R; Sauter G; Marx A; Polonski A
Biomed Res Int; 2020; 2020():5845374. PubMed ID: 33195694
[TBL] [Abstract][Full Text] [Related]
3. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors.
Hashimoto Y; Skacel M; Adams JC
BMC Cancer; 2008 Jun; 8():185. PubMed ID: 18590537
[TBL] [Abstract][Full Text] [Related]
4. Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.
Tiemann K; Weigel MT; Alkatout I; Wenners AS; Mundhenke H; Schäfer FW; Bauer M; Schem C; Maass N; Jonat W; Mundhenke C
Anticancer Res; 2014 Jul; 34(7):3607-16. PubMed ID: 24982376
[TBL] [Abstract][Full Text] [Related]
5. Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models.
Schönfeld K; Herbener P; Zuber C; Häder T; Bernöster K; Uherek C; Schüttrumpf J
Pharm Res; 2018 Apr; 35(6):118. PubMed ID: 29666962
[TBL] [Abstract][Full Text] [Related]
6. Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer.
Ismail Y; Zakaria AS; Allam R; Götte M; Ibrahim SA; Hassan H
Pathol Res Pract; 2024 Jan; 253():154994. PubMed ID: 38071886
[TBL] [Abstract][Full Text] [Related]
7. Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer.
Lebok P; Huber J; Burandt EC; Lebeau A; Marx AH; Terracciano L; Heilenkötter U; Jänicke F; Müller V; Paluchowski P; Geist S; Wilke C; Simon R; Sauter G; Quaas A
Mol Med Rep; 2016 Aug; 14(2):1443-50. PubMed ID: 27357606
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues.
Kind S; Merenkow C; Büscheck F; Möller K; Dum D; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Göbel C; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Clauditz TS; Simon R; Sauter G; Wilczak W; Bawahab AA; Izbicki JR; Perez D; Marx A
Dis Markers; 2019; 2019():4928315. PubMed ID: 31976021
[TBL] [Abstract][Full Text] [Related]
9. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
[TBL] [Abstract][Full Text] [Related]
10. Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases.
Kambham N; Kong C; Longacre TA; Natkunam Y
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):304-10. PubMed ID: 16280658
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of syndecan-1 expression in breast cancer.
Leivonen M; Lundin J; Nordling S; von Boguslawski K; Haglund C
Oncology; 2004; 67(1):11-8. PubMed ID: 15459490
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases.
Kim SY; Choi EJ; Yun JA; Jung ES; Oh ST; Kim JG; Kang WK; Lee SH
Int J Med Sci; 2015; 12(2):92-9. PubMed ID: 25589885
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.
Mirza S; Rakha EA; Alshareeda A; Mohibi S; Zhao X; Katafiasz BJ; Wang J; Gurumurthy CB; Bele A; Ellis IO; Green AR; Band H; Band V
Breast Cancer Res Treat; 2013 Feb; 137(3):721-31. PubMed ID: 23288344
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy.
Têtu B; Brisson J
Cancer; 1994 May; 73(9):2359-65. PubMed ID: 7909490
[TBL] [Abstract][Full Text] [Related]
19. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
20. erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody.
Keshgegian AA; Cnaan A
Am J Clin Pathol; 1997 Oct; 108(4):456-63. PubMed ID: 9322600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
